Higher-Dose (23 mg/day) Donepezil Formulation for the Treatment of Patients with Moderate-to-Severe Alzheimer's Disease

Subgroup Analysis of US and Non-US Patients in a Global Study of High-Dose Donepezil (23 mg) in Moderate and Severe Alzheimer’s Disease

(2012) Stephen Salloway et al.   American Journal of Alzheimers Disease and Other Dementias

Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimer’s Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine

(2012) Rachelle S. Doody et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

(2011) Martin Farlow et al.   BMC Neurology

Changes in Nursing Burden Following Memantine for Agitation and Aggression in Long-Term Care Residents with Moderate to Severe Alzheimerʼs Disease

(2011) Nathan Herrmann et al.   CNS DRUGS

Donepezil Dosing Strategies: Pharmacokinetic Considerations

(2011) Irving H. Gomolin et al.   Journal of the American Medical Directors Association

Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease

(2011) Steven H Ferris et al.   Alzheimers Research & Therapy

Caregiver Burden in Alzheimer Disease: Cross-Sectional and Longitudinal Patient Correlates

(2010) Somaia Mohamed et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study

(2010) Martin R. Farlow et al.   CLINICAL THERAPEUTICS

Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease

(2010) Niklas Bergvall et al.   INTERNATIONAL PSYCHOGERIATRICS

Safety and Tolerability of Donepezil at Doses up to 20 mg/day

(2009) Rachelle S Doody et al.   DRUGS & AGING

Predictors of Nursing Home Admission for Persons with Dementia

(2009) Joseph E. Gaugler et al.   MEDICAL CARE

Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan

(2009) Motohiro NOZAWA et al.   Psychogeriatrics

Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial

(2008) Akira Homma et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

(2007) S. Gauthier et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY